Xeris Biopharma Holdings Balance Sheet (2020-2026)

Reported Financials

Xeris Biopharma Holdings Quarterly Balance Sheet

Periods 25 quarters

Latest Sep 2026

Xeris Biopharma Holdings reported total assets of $423.22M and total liabilities of $374.44M for the quarter ended Sep 2026, up 14.3% year over year. This balance sheet covers 25 quarters of results from Sep 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	67.27M	103.77M	95.34M	84.11M	121.97M	50.98M	46.17M	46.14M	67.45M	62.69M	57.60M	59.23M	71.62M	58.44M	59.29M	91.60M	111.04M	111.75M	121.75M	131.08M
Short-term InvestmentsInvestments (Current)	35.16M	28.38M	16.21M	9.32M		44.12M	34.50M	19.83M	5.00M	24.66M	19.96M	10.17M
Cash & Current Investments	102.43M	132.15M	111.55M	93.43M	121.97M	95.10M	80.67M	65.98M	72.45M	87.35M	77.57M	69.40M	71.62M	58.44M	59.29M	91.60M	111.04M	111.75M	121.75M	131.08M
Receivables - NetNet Receivables	17.46M	23.38M	25.76M	27.52M	30.83M	30.86M	30.23M	45.97M	39.20M	37.41M	42.44M	41.14M	40.42M	46.33M	53.05M	53.75M	51.05M	56.30M	58.11M	68.60M
Receivables	17.46M	23.38M	25.76M	27.52M	30.83M	30.86M	30.23M	45.97M	39.20M	37.41M	42.44M	41.14M	40.42M	46.33M	53.05M	53.75M	51.05M	56.30M	58.11M	68.60M
Inventory	18.12M	16.87M	17.89M	20.12M	24.74M	29.04M	36.54M	38.14M	38.84M	40.88M	42.98M	45.12M	48.18M	52.69M	67.28M	67.46M	68.67M	74.23M	80.93M	76.93M
Prepaid Assets	4.59M	5.15M	6.01M	7.85M	9.29M	10.51M	8.31M	7.97M	5.78M	7.64M	7.36M	7.14M	7.45M	6.03M	5.96M	11.21M	9.55M	9.40M	13.98M	12.66M
Current Assets	142.60M	177.55M	161.21M	148.92M	186.82M	165.51M	155.74M	158.05M	156.26M	173.28M	170.34M	162.80M	167.66M	163.49M	185.58M	224.02M	240.31M	251.68M	274.76M	289.27M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	6.63M	6.29M	6.17M	5.75M	5.52M	6.48M	6.55M	6.19M	5.97M	5.78M	5.83M	5.61M	5.56M	5.26M	5.28M	4.95M	4.95M	5.03M	4.83M	4.64M
Long-Term Investments
Goodwill	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M	22.86M
Intangibles	131.45M	128.74M	126.03M	123.32M	120.61M	117.90M	115.19M	112.48M	109.76M	107.05M	104.34M	101.63M	98.92M	96.21M	93.50M	90.79M	88.08M	85.37M	82.66M	79.95M
Goodwill & Intangibles	154.31M	151.60M	148.89M	146.18M	143.47M	140.76M	138.05M	135.33M	132.62M	129.91M	127.20M	124.49M	121.78M	119.07M	116.36M	113.65M	110.94M	108.23M	105.52M	102.81M
Other Non-Current Assets	0.83M	2.18M	2.35M	2.17M	4.73M	4.73M	4.81M	4.81M	4.54M	4.61M	5.49M	5.44M	5.41M	5.10M	5.06M	5.32M	5.22M	5.12M	5.03M	4.93M
Non-Current Assets	161.77M	160.07M	157.41M	154.10M	157.70M	155.85M	173.04M	169.73M	166.34M	163.34M	161.39M	158.31M	155.40M	151.96M	149.11M	146.17M	143.21M	140.33M	137.15M	133.95M
Assets	304.36M	337.62M	318.62M	303.02M	344.52M	321.36M	328.78M	327.78M	322.60M	336.62M	331.73M	321.10M	323.06M	315.45M	334.69M	370.19M	383.53M	392.01M	411.91M	423.22M
Liabilities
Current Liabilities
Accounts Payables	8.92M	11.09M	6.63M	3.92M	4.61M	11.98M	11.62M	12.08M	11.57M	7.09M	5.80M	7.45M	2.29M	6.35M	9.46M	6.53M	3.08M	11.47M	9.34M	8.04M
Payables	8.92M	11.09M	6.63M	3.92M	4.61M	11.98M	11.62M	12.08M	11.57M	7.09M	5.80M	7.45M	2.29M	6.35M	9.46M	6.53M	3.08M	11.47M	9.34M	8.04M
Accumulated Expenses	49.09M	34.36M	36.95M	37.71M	36.79M	20.15M	19.41M	19.07M	23.51M	22.39M	23.49M	23.54M	27.72M	20.05M	24.97M	30.35M	33.16M	32.29M	39.71M	47.37M
Other Accumulated Expenses	1.99M	0.62M	0.92M	0.34M	2.66M	2.76M	1.72M	1.12M	1.17M	0.80M	1.00M	0.68M	1.09M	0.16M	1.63M	2.65M	4.89M	4.35M	4.98M	4.02M
Short term Debt												15.06M	15.10M	11.96M					63.78M
Current Deferred Revenue					1.58M	1.45M	1.94M	2.37M	3.50M	4.62M	5.31M	6.04M	6.08M	6.12M	6.16M	6.19M	6.23M	6.27M	6.31M	6.35M
Total Current Liabilities	79.04M	66.49M	64.55M	68.56M	73.62M	81.42M	79.68M	87.04M	95.19M	73.08M	75.49M	91.01M	100.44M	95.07M	95.17M	116.20M	109.57M	118.59M	189.57M	134.48M
Non-Current Liabilities
Non-Current Debt									190.93M				217.01M	217.81M	218.63M	219.47M	220.34M	221.22M	188.81M	189.71M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax	4.94M	4.53M	4.20M	3.86M	3.52M	3.52M	2.84M	2.50M	2.27M	2.58M	3.32M
Operating Leases					9.40M	9.35M	34.87M	35.15M	34.76M	34.40M	34.02M	33.64M	33.26M	32.87M	32.44M	31.99M	31.53M	31.06M	30.54M	30.00M
Other Non-Current Liabilities	31.09M	32.50M	37.87M	37.06M	25.69M	9.40M	9.56M	8.80M	6.23M	7.09M	8.13M	8.55M	1.97M	4.83M	7.75M	3.39M	8.40M	8.13M	12.72M	20.24M
Total Non-Current Liabilities	178.04M	208.67M	206.81M	210.92M	273.65M	281.91M	305.57M	315.12M	323.16M	338.71M	342.89M	340.88M	350.71M	345.75M	346.24M	367.66M	361.44M	370.88M	408.92M	354.20M
Total Liabilities	209.13M	241.17M	244.67M	247.98M	299.34M	291.31M	315.14M	323.92M	329.38M	345.79M	351.02M	349.43M	352.68M	350.58M	353.99M	371.05M	369.84M	379.00M	421.64M	374.44M
Shareholder's Equity
Total Debt	88.07M	137.64M	138.07M	138.51M	187.08M	187.62M	188.18M	190.42M	190.93M	229.67M	230.48M	216.23M	232.11M	229.76M	218.63M	219.47M	220.34M	221.22M	252.59M	189.71M
Common Equity	95.23M	96.46M	73.94M	55.04M	45.19M	30.05M	13.64M	3.87M	-6.78M	-9.18M	-19.29M	-28.32M	-29.62M	-35.13M	-19.30M	-0.86M	13.69M	13.01M	-9.73M	48.78M
Liabilities and Shareholders Equity	304.36M	337.62M	318.62M	303.02M	344.52M	321.36M	328.78M	327.78M	322.60M	336.62M	331.73M	321.10M	323.06M	315.45M	334.69M	370.19M	383.53M	392.01M	411.91M	423.22M
Retained Earnings	-460.11M	-493.82M	-520.01M	-541.84M	-554.77M	-571.60M	-591.45M	-603.64M	-617.03M	-636.01M	-651.01M	-666.75M	-671.86M	-681.10M	-683.01M	-682.40M	-671.31M	-669.07M	-700.17M	-688.88M

Xeris Biopharma Holdings Balance Sheet API

Pull Xeris Biopharma Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XERS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "XERS", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=XERS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Xeris Biopharma Holdings XERS Balance Sheet (2020-2026)

Xeris Biopharma Holdings Quarterly Balance Sheet

Xeris Biopharma Holdings Balance Sheet API

Create an account

Sign In

Reset Password